Sema4, a health data research company, announced Thursday it opened a 70,000-square foot building in Stamford with more than 300 workers processing genomic tests, its third site in Connecticut to keep pace with growing demand for data-driven health care.
The Stamford laboratory complements Sema4 1/4 u2032s Branford lab that was expanded earlier this year and its headquarters, also in Stamford.
The new Sema4 lab replaces one in New York City, providing additional capacity to support genomic testing and expand digital health services. With its Stamford and Branford labs, Sema4 will increase its ability to provide health information across several thousand genetically identifiable diseases to patients.
Eric Schadt, founder and chief executive of Sema4, said the new Stamford site will be a hub for research and development for predictive modeling and information-driven testing.
In addition to lab employees, the Stamford facility also has capacity for 100 genetic counselors, bioinformatics specialists and support service staff. Sema4 has more than 500 employees in Connecticut across its two lab facilities and Stamford headquarters. Its workforce has quadrupled over the last three years.
Sema4 also maintains an office in New York City.
The company’s growth reflects rapid advances in personal medicine and genomics, which focuses on sequencing and analyzing an organism’s genome, the DNA content in a cell.
The state announced in 2018 a $6 million loan to Sema4 to move its New York City laboratory to Connecticut and create 400 jobs. “We were kind of busting at the seams,” Schadt said at the time.
In Connecticut, Sema4 is part of an expanding cluster of medical technology companies, such as Arvinas, a New Haven cancer pharmaceutical company, and the Guilford medical device company Butterfly Network.
Stephen Singer can be reached at [email protected]
©2020 The Hartford Courant (Hartford, Conn.)
Visit The Hartford Courant (Hartford, Conn.) at www.courant.com
Distributed by Tribune Content Agency, LLC.